Consultant Clinical Oncologist


Dr Joss Adams

Consultant in Reading since – 2006

Where qualified

I graduated from Cambridge University in 1995 and completed both my junior medical training and my oncology specialist training in Oxford.

Clinical Involvement

I am principal investigator for clinical trials in lung and breast cancer at the Royal Berkshire Hospital, Reading. I also refer patients for clinical trials where appropriate (including the Royal Marsden and University College Hospital, London).

Other clinical involvement

Clinical Governance Lead in the Berkshire Cancer Centre, Royal Berkshire Hospital, Reading 2006-2011.

Clinical lead for Chemotherapy in the Berkshire Cancer Centre, Royal Berkshire Hospital, Reading 2011-2017.

Clinical Supervisor for specialist oncology trainees.


Addition of Apatorsen, an inhibitor of Hsp27, to first-line gemcitabine/carboplatin in advanced squamous cell lung cancer: Design of the Cedar study. ASCO 2016.

A Phase II, randomised, open-label study of Gemcitabine/Carboplatin first-line chemotherapy in combination with or without the antisense oligonucleotide Apatorsen (OGX-427) in advanced squamous cell lung cancers ESMO 2017.

I have also written chapters for the Oxford Handbook of Emergencies in Oncology, and Problem solving in Oncology.


2014: Cycled from Reading to Barcelona on a tandem with Nurse Consultant Mark Foulkes on a charity cycle ride to raise funds to facilitate the local delivery of chemotherapy for patients in West Berkshire.

2017 Nominated for National Oncology Registrars’ Forum Trainer Award.


I am fully registered with the GMC (4259509) and hold a certificate of completion of specialist training in Clinical Oncology.

I have accepted educational grants to fund attendance at both national and international cancer conferences. I have provided training and updates for pharmaceutical companies when requested. I have no financial interests in any pharmaceutical company.

I am an investor in the Genesis Care,Windsor, Diagnostic and Oncology Centre.